Kidney disease can be either acute kidney injury (AKI) or chronic kidney disease (CKD) and
it can lead to the development of functional organ failure. Mesenchymal stem cells (MSCs) …

Acute renal failure (ARF; acute kidney injury—according to the more recent classification) is
emerging as a public health problem. Despite major advances in supportive therapy, the …

Acute kidney injury, formerly known as acute renal failure, is a pathological condition in
which ischemia or toxic damage contributes to the loss of renal proximal tubule epithelial …

Today, the prevalence of kidney diseases is increasing around the world, but there has still
been no effective medical treatment. The therapeutic choices are confined to supportive …

Chronic renal failure is an important clinical problem with significant socioeconomic impact
worldwide. Despite advances in renal replacement therapies and organ transplantation …

Introduction Studies have shown that stem cells exert their therapeutic effects on acute
kidney injury (AKI) through paracrine/endocrine actions. If the protective effect is mediated in …

Renal failure is one of the most important causes of mortality and morbidity all over the
world. Acute kidney injury (AKI) is a major clinical problem that affects up to 5% of all …

The susceptibility of developing acute renal failure depends on the ability of the kidney to
recover from acute injury and regain normal function. Recently, the possible contribution of …

Over the last decade, stem cells have been the topic of much debate and investigation for
their regenerative potential in the case of renal injury. This review focuses on bone marrow …

The kidney has been considered a highly terminally differentiated organ of the body, and its
proliferative potential is low, with the result that it has been thought of as a most unlikely …